NCT03900273View on ClinicalTrials.gov

Development of Novel Measures for Alzheimer's Disease Prevention Trials

NASuspendedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 25, 2019

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Healthy Participants
Interventions
OTHER

No Practice Effects (NPE) cognitive battery, and Miami Computerized Functional Assessment Scale (CFAS)

Novel measures of Cognitive and Everyday function

OTHER

Preclinical Alzheimer's Cognitive Composite (PACC), Alzheimer's Disease Assessment Scale-Cognitive Scale (ADAS-Cog), and Functional Assessment Questionnaire (FAQ)

Established measures of Cognitive and Everyday Function

Trial Locations (4)

11030

The Feinstein Institute for Medical Research, Manhasset

11032

New York State Psychiatric Institute, New York

33136

University of Miami, Miami

90033

University of Southern California, Los Angeles

Sponsors
All Listed Sponsors
collaborator

Columbia University

OTHER

collaborator

University of Southern California

OTHER

collaborator

Feinstein Institute for Medical Research

OTHER

collaborator

University of Miami

OTHER

lead

New York State Psychiatric Institute

OTHER